nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—type 2 diabetes mellitus—type 1 diabetes mellitus	0.509	1	CtDrD
Gliclazide—ABCC8—type 1 diabetes mellitus	0.218	0.54	CbGaD
Gliclazide—KCNJ11—type 1 diabetes mellitus	0.154	0.381	CbGaD
Gliclazide—ALB—type 1 diabetes mellitus	0.032	0.0793	CbGaD
Gliclazide—ABCC8—penis—type 1 diabetes mellitus	0.00295	0.299	CbGeAlD
Gliclazide—VEGFA—Enalapril—Ramipril—type 1 diabetes mellitus	0.00163	1	CbGdCrCtD
Gliclazide—Cerebrovascular disorder—Ramipril—type 1 diabetes mellitus	0.00107	0.0379	CcSEcCtD
Gliclazide—VEGFA—islet of Langerhans—type 1 diabetes mellitus	0.000995	0.101	CbGeAlD
Gliclazide—VEGFA—nephron tubule—type 1 diabetes mellitus	0.000801	0.0812	CbGeAlD
Gliclazide—Digestion impaired—Ramipril—type 1 diabetes mellitus	0.000714	0.0254	CcSEcCtD
Gliclazide—KCNJ11—islet of Langerhans—type 1 diabetes mellitus	0.000712	0.0721	CbGeAlD
Gliclazide—VEGFA—pancreas—type 1 diabetes mellitus	0.0007	0.0709	CbGeAlD
Gliclazide—Neuralgia—Ramipril—type 1 diabetes mellitus	0.000687	0.0244	CcSEcCtD
Gliclazide—ABCC8—islet of Langerhans—type 1 diabetes mellitus	0.000656	0.0664	CbGeAlD
Gliclazide—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.000551	0.0196	CcSEcCtD
Gliclazide—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.000544	0.0193	CcSEcCtD
Gliclazide—KCNJ11—cardiovascular system—type 1 diabetes mellitus	0.000515	0.0522	CbGeAlD
Gliclazide—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.000502	0.0178	CcSEcCtD
Gliclazide—KCNJ11—pancreas—type 1 diabetes mellitus	0.0005	0.0507	CbGeAlD
Gliclazide—ABCC8—cardiovascular system—type 1 diabetes mellitus	0.000474	0.048	CbGeAlD
Gliclazide—Tolazamide—ABCC8—type 1 diabetes mellitus	0.000465	0.115	CrCbGaD
Gliclazide—ABCC8—kidney—type 1 diabetes mellitus	0.000464	0.047	CbGeAlD
Gliclazide—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.000464	0.0165	CcSEcCtD
Gliclazide—ABCC8—pancreas—type 1 diabetes mellitus	0.000461	0.0467	CbGeAlD
Gliclazide—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.000451	0.016	CcSEcCtD
Gliclazide—Neuropathy—Ramipril—type 1 diabetes mellitus	0.000448	0.0159	CcSEcCtD
Gliclazide—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.000434	0.0154	CcSEcCtD
Gliclazide—KCNJ11—lymphoid tissue—type 1 diabetes mellitus	0.000433	0.0438	CbGeAlD
Gliclazide—Urine output increased—Ramipril—type 1 diabetes mellitus	0.000432	0.0153	CcSEcCtD
Gliclazide—Glisoxepide—ABCC8—type 1 diabetes mellitus	0.000421	0.104	CrCbGaD
Gliclazide—Glimepiride—ABCC8—type 1 diabetes mellitus	0.000414	0.103	CrCbGaD
Gliclazide—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.0004	0.0142	CcSEcCtD
Gliclazide—Polyuria—Ramipril—type 1 diabetes mellitus	0.000395	0.014	CcSEcCtD
Gliclazide—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.000395	0.014	CcSEcCtD
Gliclazide—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.000391	0.0139	CcSEcCtD
Gliclazide—Deafness—Ramipril—type 1 diabetes mellitus	0.000388	0.0138	CcSEcCtD
Gliclazide—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.000386	0.0137	CcSEcCtD
Gliclazide—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.000384	0.0136	CcSEcCtD
Gliclazide—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.000376	0.0133	CcSEcCtD
Gliclazide—Renal impairment—Ramipril—type 1 diabetes mellitus	0.000364	0.0129	CcSEcCtD
Gliclazide—Glipizide—ABCC8—type 1 diabetes mellitus	0.000359	0.0892	CrCbGaD
Gliclazide—Arthritis—Ramipril—type 1 diabetes mellitus	0.000357	0.0127	CcSEcCtD
Gliclazide—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.000355	0.0126	CcSEcCtD
Gliclazide—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.000355	0.0126	CcSEcCtD
Gliclazide—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.000354	0.0126	CcSEcCtD
Gliclazide—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.000348	0.0124	CcSEcCtD
Gliclazide—Tolazamide—KCNJ11—type 1 diabetes mellitus	0.000328	0.0813	CrCbGaD
Gliclazide—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.000312	0.0111	CcSEcCtD
Gliclazide—Gastritis—Ramipril—type 1 diabetes mellitus	0.000307	0.0109	CcSEcCtD
Gliclazide—Asthma—Ramipril—type 1 diabetes mellitus	0.0003	0.0106	CcSEcCtD
Gliclazide—Glisoxepide—KCNJ11—type 1 diabetes mellitus	0.000296	0.0736	CrCbGaD
Gliclazide—Glimepiride—KCNJ11—type 1 diabetes mellitus	0.000292	0.0725	CrCbGaD
Gliclazide—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.000292	0.0104	CcSEcCtD
Gliclazide—Bronchitis—Ramipril—type 1 diabetes mellitus	0.000288	0.0102	CcSEcCtD
Gliclazide—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.000287	0.0102	CcSEcCtD
Gliclazide—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.000285	0.0101	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.000278	0.00989	CcSEcCtD
Gliclazide—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000276	0.00981	CcSEcCtD
Gliclazide—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000274	0.00972	CcSEcCtD
Gliclazide—Weight increased—Ramipril—type 1 diabetes mellitus	0.000273	0.00969	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000265	0.00941	CcSEcCtD
Gliclazide—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.000263	0.00936	CcSEcCtD
Gliclazide—Renal failure—Ramipril—type 1 diabetes mellitus	0.000263	0.00933	CcSEcCtD
Gliclazide—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.000262	0.0093	CcSEcCtD
Gliclazide—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000262	0.0093	CcSEcCtD
Gliclazide—Jaundice—Ramipril—type 1 diabetes mellitus	0.00026	0.00925	CcSEcCtD
Gliclazide—Chlorpropamide—ABCC8—type 1 diabetes mellitus	0.00026	0.0645	CrCbGaD
Gliclazide—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00026	0.00923	CcSEcCtD
Gliclazide—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00026	0.00923	CcSEcCtD
Gliclazide—Sweating—Ramipril—type 1 diabetes mellitus	0.000256	0.0091	CcSEcCtD
Gliclazide—Tolbutamide—ABCC8—type 1 diabetes mellitus	0.000253	0.0629	CrCbGaD
Gliclazide—Glipizide—KCNJ11—type 1 diabetes mellitus	0.000253	0.0629	CrCbGaD
Gliclazide—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000253	0.00898	CcSEcCtD
Gliclazide—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000252	0.00895	CcSEcCtD
Gliclazide—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000251	0.00891	CcSEcCtD
Gliclazide—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000249	0.00886	CcSEcCtD
Gliclazide—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00024	0.00852	CcSEcCtD
Gliclazide—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000236	0.00839	CcSEcCtD
Gliclazide—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000231	0.00821	CcSEcCtD
Gliclazide—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000227	0.00806	CcSEcCtD
Gliclazide—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000224	0.00795	CcSEcCtD
Gliclazide—Flushing—Ramipril—type 1 diabetes mellitus	0.000223	0.00791	CcSEcCtD
Gliclazide—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000214	0.00761	CcSEcCtD
Gliclazide—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000212	0.0215	CbGeAlD
Gliclazide—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00021	0.00747	CcSEcCtD
Gliclazide—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000209	0.00742	CcSEcCtD
Gliclazide—Erythema—Ramipril—type 1 diabetes mellitus	0.000209	0.00742	CcSEcCtD
Gliclazide—Tension—Ramipril—type 1 diabetes mellitus	0.000205	0.00728	CcSEcCtD
Gliclazide—Nervousness—Ramipril—type 1 diabetes mellitus	0.000203	0.0072	CcSEcCtD
Gliclazide—Tremor—Ramipril—type 1 diabetes mellitus	0.000196	0.00695	CcSEcCtD
Gliclazide—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000194	0.00688	CcSEcCtD
Gliclazide—Agitation—Ramipril—type 1 diabetes mellitus	0.000192	0.00682	CcSEcCtD
Gliclazide—Angioedema—Ramipril—type 1 diabetes mellitus	0.000191	0.00678	CcSEcCtD
Gliclazide—Malaise—Ramipril—type 1 diabetes mellitus	0.000188	0.00669	CcSEcCtD
Gliclazide—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000187	0.00664	CcSEcCtD
Gliclazide—Palpitations—Ramipril—type 1 diabetes mellitus	0.000185	0.00656	CcSEcCtD
Gliclazide—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000184	0.00652	CcSEcCtD
Gliclazide—Chlorpropamide—KCNJ11—type 1 diabetes mellitus	0.000183	0.0454	CrCbGaD
Gliclazide—Cough—Ramipril—type 1 diabetes mellitus	0.000182	0.00647	CcSEcCtD
Gliclazide—Convulsion—Ramipril—type 1 diabetes mellitus	0.000181	0.00643	CcSEcCtD
Gliclazide—Tolbutamide—KCNJ11—type 1 diabetes mellitus	0.000178	0.0443	CrCbGaD
Gliclazide—Myalgia—Ramipril—type 1 diabetes mellitus	0.000178	0.00632	CcSEcCtD
Gliclazide—Chest pain—Ramipril—type 1 diabetes mellitus	0.000178	0.00632	CcSEcCtD
Gliclazide—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000178	0.00632	CcSEcCtD
Gliclazide—Anxiety—Ramipril—type 1 diabetes mellitus	0.000177	0.00629	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000177	0.00627	CcSEcCtD
Gliclazide—Discomfort—Ramipril—type 1 diabetes mellitus	0.000176	0.00624	CcSEcCtD
Gliclazide—Glyburide—ABCC8—type 1 diabetes mellitus	0.000175	0.0436	CrCbGaD
Gliclazide—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000174	0.00618	CcSEcCtD
Gliclazide—Confusional state—Ramipril—type 1 diabetes mellitus	0.000172	0.0061	CcSEcCtD
Gliclazide—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000167	0.00594	CcSEcCtD
Gliclazide—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000167	0.00593	CcSEcCtD
Gliclazide—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000166	0.00591	CcSEcCtD
Gliclazide—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000166	0.00588	CcSEcCtD
Gliclazide—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000165	0.00585	CcSEcCtD
Gliclazide—Hypotension—Ramipril—type 1 diabetes mellitus	0.000159	0.00566	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000155	0.00552	CcSEcCtD
Gliclazide—Insomnia—Ramipril—type 1 diabetes mellitus	0.000154	0.00548	CcSEcCtD
Gliclazide—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000153	0.00544	CcSEcCtD
Gliclazide—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000152	0.0054	CcSEcCtD
Gliclazide—Somnolence—Ramipril—type 1 diabetes mellitus	0.000151	0.00538	CcSEcCtD
Gliclazide—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00015	0.00533	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000147	0.00523	CcSEcCtD
Gliclazide—Fatigue—Ramipril—type 1 diabetes mellitus	0.000147	0.00522	CcSEcCtD
Gliclazide—Constipation—Ramipril—type 1 diabetes mellitus	0.000146	0.00518	CcSEcCtD
Gliclazide—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00014	0.00499	CcSEcCtD
Gliclazide—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000139	0.00495	CcSEcCtD
Gliclazide—Urticaria—Ramipril—type 1 diabetes mellitus	0.000135	0.00481	CcSEcCtD
Gliclazide—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000135	0.00479	CcSEcCtD
Gliclazide—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000135	0.00479	CcSEcCtD
Gliclazide—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000126	0.00446	CcSEcCtD
Gliclazide—Glyburide—KCNJ11—type 1 diabetes mellitus	0.000124	0.0307	CrCbGaD
Gliclazide—Asthenia—Ramipril—type 1 diabetes mellitus	0.000122	0.00434	CcSEcCtD
Gliclazide—Pruritus—Ramipril—type 1 diabetes mellitus	0.000121	0.00428	CcSEcCtD
Gliclazide—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000117	0.00414	CcSEcCtD
Gliclazide—Dizziness—Ramipril—type 1 diabetes mellitus	0.000113	0.004	CcSEcCtD
Gliclazide—Vomiting—Ramipril—type 1 diabetes mellitus	0.000108	0.00385	CcSEcCtD
Gliclazide—Rash—Ramipril—type 1 diabetes mellitus	0.000107	0.00382	CcSEcCtD
Gliclazide—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000107	0.00381	CcSEcCtD
Gliclazide—Headache—Ramipril—type 1 diabetes mellitus	0.000107	0.00379	CcSEcCtD
Gliclazide—Nausea—Ramipril—type 1 diabetes mellitus	0.000101	0.0036	CcSEcCtD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—IGF1—type 1 diabetes mellitus	8.38e-05	0.00191	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—ALB—type 1 diabetes mellitus	8.34e-05	0.0019	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	8.28e-05	0.00189	CbGpPWpGaD
Gliclazide—ABCC8—Integration of energy metabolism—INS—type 1 diabetes mellitus	8.07e-05	0.00184	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—PDX1—type 1 diabetes mellitus	8.05e-05	0.00184	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—HNF1A—type 1 diabetes mellitus	8.05e-05	0.00184	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	8.05e-05	0.00184	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—CASP3—type 1 diabetes mellitus	7.99e-05	0.00182	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—ALB—type 1 diabetes mellitus	7.94e-05	0.00181	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—IL6—type 1 diabetes mellitus	7.88e-05	0.0018	CbGpPWpGaD
Gliclazide—KCNJ11—Integration of energy metabolism—INS—type 1 diabetes mellitus	7.82e-05	0.00179	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IFNG—type 1 diabetes mellitus	7.68e-05	0.00175	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	7.66e-05	0.00175	CbGpPWpGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	7.62e-05	0.00174	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	7.58e-05	0.00173	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—VAV1—type 1 diabetes mellitus	7.57e-05	0.00173	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—E2F1—type 1 diabetes mellitus	7.53e-05	0.00172	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—PRKCQ—type 1 diabetes mellitus	6.91e-05	0.00158	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL1B—type 1 diabetes mellitus	6.85e-05	0.00156	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—CASP3—type 1 diabetes mellitus	6.84e-05	0.00156	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL2—type 1 diabetes mellitus	6.83e-05	0.00156	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—HBA1—type 1 diabetes mellitus	6.8e-05	0.00155	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—STAT3—type 1 diabetes mellitus	6.72e-05	0.00153	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—VAV1—type 1 diabetes mellitus	6.71e-05	0.00153	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—EGFR—type 1 diabetes mellitus	6.69e-05	0.00153	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—SOD2—type 1 diabetes mellitus	6.57e-05	0.0015	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—SELL—type 1 diabetes mellitus	6.44e-05	0.00147	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—TYK2—type 1 diabetes mellitus	6.44e-05	0.00147	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—NOS3—type 1 diabetes mellitus	6.32e-05	0.00144	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	6.24e-05	0.00142	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CDK4—type 1 diabetes mellitus	6.14e-05	0.0014	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—TYK2—type 1 diabetes mellitus	6.08e-05	0.00139	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IGF2—type 1 diabetes mellitus	6.08e-05	0.00139	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	5.99e-05	0.00137	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—IL6—type 1 diabetes mellitus	5.98e-05	0.00136	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—NOS3—type 1 diabetes mellitus	5.96e-05	0.00136	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—CAT—type 1 diabetes mellitus	5.64e-05	0.00129	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—CRP—type 1 diabetes mellitus	5.5e-05	0.00126	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	5.49e-05	0.00125	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—SOD2—type 1 diabetes mellitus	5.34e-05	0.00122	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CAT—type 1 diabetes mellitus	5.27e-05	0.0012	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—G6PC2—type 1 diabetes mellitus	5.25e-05	0.0012	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL4—type 1 diabetes mellitus	5.18e-05	0.00118	CbGpPWpGaD
Gliclazide—ALB—FOXA2 and FOXA3 transcription factor networks—INS—type 1 diabetes mellitus	5.18e-05	0.00118	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—IL6—type 1 diabetes mellitus	5.14e-05	0.00117	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	5.11e-05	0.00117	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SIRPG—type 1 diabetes mellitus	5.09e-05	0.00116	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—PRKCQ—type 1 diabetes mellitus	5.09e-05	0.00116	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	5.09e-05	0.00116	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	5.06e-05	0.00115	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—ITPR3—type 1 diabetes mellitus	5.05e-05	0.00115	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	5.02e-05	0.00114	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—SOD2—type 1 diabetes mellitus	5e-05	0.00114	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TNF—type 1 diabetes mellitus	4.97e-05	0.00113	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—IGF2—type 1 diabetes mellitus	4.83e-05	0.0011	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IAPP—type 1 diabetes mellitus	4.82e-05	0.0011	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—E2F1—type 1 diabetes mellitus	4.82e-05	0.0011	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—SH2B3—type 1 diabetes mellitus	4.76e-05	0.00109	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—type 1 diabetes mellitus	4.6e-05	0.00105	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—INS—type 1 diabetes mellitus	4.6e-05	0.00105	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	4.48e-05	0.00102	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—CRP—type 1 diabetes mellitus	4.48e-05	0.00102	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	4.41e-05	0.00101	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—IGF1—type 1 diabetes mellitus	4.4e-05	0.001	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	4.38e-05	0.001	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	4.25e-05	0.000969	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—HBA2—type 1 diabetes mellitus	4.12e-05	0.000941	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CASP3—type 1 diabetes mellitus	4.07e-05	0.000929	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—HBA2—type 1 diabetes mellitus	4e-05	0.000913	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	3.98e-05	0.000907	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	3.97e-05	0.000905	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDK4—type 1 diabetes mellitus	3.93e-05	0.000896	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	3.9e-05	0.00089	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—G6PC2—type 1 diabetes mellitus	3.88e-05	0.000885	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IFNG—type 1 diabetes mellitus	3.85e-05	0.000878	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—NOS1—type 1 diabetes mellitus	3.8e-05	0.000868	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—G6PC2—type 1 diabetes mellitus	3.76e-05	0.000858	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—INS—type 1 diabetes mellitus	3.74e-05	0.000854	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—ALB—type 1 diabetes mellitus	3.7e-05	0.000844	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—PRKCQ—type 1 diabetes mellitus	3.63e-05	0.000828	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—PRKCQ—type 1 diabetes mellitus	3.56e-05	0.000813	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	3.56e-05	0.000812	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—GSTT1—type 1 diabetes mellitus	3.49e-05	0.000796	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC18A2—type 1 diabetes mellitus	3.49e-05	0.000796	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—ITPR3—type 1 diabetes mellitus	3.46e-05	0.00079	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—VAV1—type 1 diabetes mellitus	3.46e-05	0.000789	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL1B—type 1 diabetes mellitus	3.43e-05	0.000783	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	3.37e-05	0.00077	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ABCC8—type 1 diabetes mellitus	3.26e-05	0.000744	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—CP—type 1 diabetes mellitus	3.21e-05	0.000732	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC11A1—type 1 diabetes mellitus	3.18e-05	0.000726	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—GSTT1—type 1 diabetes mellitus	3.18e-05	0.000726	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—IL6—type 1 diabetes mellitus	3.15e-05	0.000718	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IGF2—type 1 diabetes mellitus	3.13e-05	0.000715	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IFNG—type 1 diabetes mellitus	3.13e-05	0.000714	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—EGFR—type 1 diabetes mellitus	3.11e-05	0.00071	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—IGF1—type 1 diabetes mellitus	3.1e-05	0.000708	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	3e-05	0.000684	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	2.97e-05	0.000678	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—IL6—type 1 diabetes mellitus	2.97e-05	0.000678	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—type 1 diabetes mellitus	2.96e-05	0.000675	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	2.89e-05	0.000658	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL1B—type 1 diabetes mellitus	2.79e-05	0.000637	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL2—type 1 diabetes mellitus	2.78e-05	0.000635	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	2.67e-05	0.000609	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—KCNJ11—type 1 diabetes mellitus	2.66e-05	0.000606	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—TYK2—type 1 diabetes mellitus	2.65e-05	0.000605	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2RA—type 1 diabetes mellitus	2.64e-05	0.000602	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—EGFR—type 1 diabetes mellitus	2.59e-05	0.00059	CbGpPWpGaD
Gliclazide—Glyburide—ALB—type 1 diabetes mellitus	2.58e-05	0.0064	CrCbGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.58e-05	0.000588	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—type 1 diabetes mellitus	2.49e-05	0.000568	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	2.49e-05	0.000568	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.45e-05	0.00056	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PRKCQ—type 1 diabetes mellitus	2.44e-05	0.000556	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CDK4—type 1 diabetes mellitus	2.38e-05	0.000543	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VAV1—type 1 diabetes mellitus	2.37e-05	0.00054	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	2.33e-05	0.000531	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	2.31e-05	0.000528	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SELL—type 1 diabetes mellitus	2.27e-05	0.000519	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—NOS2—type 1 diabetes mellitus	2.27e-05	0.000517	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ITPR3—type 1 diabetes mellitus	2.24e-05	0.000512	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	2.22e-05	0.000506	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—STAT3—type 1 diabetes mellitus	2.19e-05	0.000499	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ITPR3—type 1 diabetes mellitus	2.17e-05	0.000496	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF2—type 1 diabetes mellitus	2.14e-05	0.000489	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—INS—type 1 diabetes mellitus	2.12e-05	0.000484	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—HBA1—type 1 diabetes mellitus	2.11e-05	0.000482	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—APOC3—type 1 diabetes mellitus	2.1e-05	0.000479	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTT1—type 1 diabetes mellitus	2.06e-05	0.00047	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GAL—type 1 diabetes mellitus	2.05e-05	0.000469	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—HBA1—type 1 diabetes mellitus	2.05e-05	0.000467	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—APOC3—type 1 diabetes mellitus	2.03e-05	0.000464	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL11—type 1 diabetes mellitus	2.03e-05	0.000463	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL20—type 1 diabetes mellitus	2.03e-05	0.000463	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—type 1 diabetes mellitus	2.03e-05	0.000462	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IGF1—type 1 diabetes mellitus	2.01e-05	0.000459	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL6—type 1 diabetes mellitus	2.01e-05	0.000459	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTT1—type 1 diabetes mellitus	2e-05	0.000456	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CHRM2—type 1 diabetes mellitus	1.91e-05	0.000436	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—ALB—type 1 diabetes mellitus	1.91e-05	0.000435	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TYK2—type 1 diabetes mellitus	1.89e-05	0.000432	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—NOS3—type 1 diabetes mellitus	1.82e-05	0.000416	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.81e-05	0.000412	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	1.8e-05	0.000412	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—ITPR3—type 1 diabetes mellitus	1.78e-05	0.000407	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	1.77e-05	0.000404	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ITPR3—type 1 diabetes mellitus	1.71e-05	0.000391	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—EGFR—type 1 diabetes mellitus	1.69e-05	0.000385	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SH2B3—type 1 diabetes mellitus	1.68e-05	0.000383	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GCG—type 1 diabetes mellitus	1.64e-05	0.000375	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—type 1 diabetes mellitus	1.64e-05	0.000373	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	1.63e-05	0.000372	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	1.62e-05	0.000369	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SH2B3—type 1 diabetes mellitus	1.61e-05	0.000368	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	1.61e-05	0.000367	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APOC3—type 1 diabetes mellitus	1.6e-05	0.000366	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IAPP—type 1 diabetes mellitus	1.6e-05	0.000366	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GCG—type 1 diabetes mellitus	1.59e-05	0.000363	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2—type 1 diabetes mellitus	1.55e-05	0.000353	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—type 1 diabetes mellitus	1.53e-05	0.000349	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	1.52e-05	0.000347	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SST—type 1 diabetes mellitus	1.41e-05	0.000321	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.4e-05	0.00032	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CAT—type 1 diabetes mellitus	1.39e-05	0.000317	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	1.38e-05	0.000314	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	1.36e-05	0.000311	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CAT—type 1 diabetes mellitus	1.35e-05	0.000308	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS1—type 1 diabetes mellitus	1.34e-05	0.000306	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HBA2—type 1 diabetes mellitus	1.33e-05	0.000303	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—STAT3—type 1 diabetes mellitus	1.33e-05	0.000303	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	1.3e-05	0.000296	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—type 1 diabetes mellitus	1.3e-05	0.000296	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PRKCQ—type 1 diabetes mellitus	1.26e-05	0.000287	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GCG—type 1 diabetes mellitus	1.25e-05	0.000286	CbGpPWpGaD
Gliclazide—ALB—Metabolism—G6PC2—type 1 diabetes mellitus	1.25e-05	0.000285	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	1.24e-05	0.000284	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	1.22e-05	0.000279	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.21e-05	0.000275	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—EGFR—type 1 diabetes mellitus	1.2e-05	0.000275	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	1.19e-05	0.000272	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.17e-05	0.000268	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.17e-05	0.000267	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—type 1 diabetes mellitus	1.15e-05	0.000262	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	1.12e-05	0.000256	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	1.11e-05	0.000252	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	1.09e-05	0.000248	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	1.08e-05	0.000247	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.06e-05	0.000242	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	1.06e-05	0.000241	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	1.02e-05	0.000234	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CD86—type 1 diabetes mellitus	1.02e-05	0.000233	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	9.73e-06	0.000222	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—E2F1—type 1 diabetes mellitus	9.7e-06	0.000221	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	9.3e-06	0.000212	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—type 1 diabetes mellitus	9.26e-06	0.000211	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—INS—type 1 diabetes mellitus	9.22e-06	0.000211	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.22e-06	0.00021	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.07e-06	0.000207	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—INS—type 1 diabetes mellitus	8.95e-06	0.000204	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.94e-06	0.000204	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	8.87e-06	0.000202	CbGpPWpGaD
Gliclazide—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	8.57e-06	0.000196	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALB—type 1 diabetes mellitus	8.46e-06	0.000193	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALB—type 1 diabetes mellitus	8.2e-06	0.000187	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NOS3—type 1 diabetes mellitus	8.09e-06	0.000185	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	8e-06	0.000183	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NOS3—type 1 diabetes mellitus	7.84e-06	0.000179	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	7.69e-06	0.000176	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CD80—type 1 diabetes mellitus	7.46e-06	0.00017	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	7.23e-06	0.000165	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	7.1e-06	0.000162	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—INS—type 1 diabetes mellitus	7.05e-06	0.000161	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	7.01e-06	0.00016	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.82e-06	0.000156	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HBA1—type 1 diabetes mellitus	6.81e-06	0.000155	CbGpPWpGaD
Gliclazide—ALB—Metabolism—APOC3—type 1 diabetes mellitus	6.76e-06	0.000154	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	6.64e-06	0.000152	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	6.49e-06	0.000148	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	6.43e-06	0.000147	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.3e-06	0.000144	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.18e-06	0.000141	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	6.11e-06	0.000139	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	6.07e-06	0.000139	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	5.96e-06	0.000136	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	5.92e-06	0.000135	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	5.57e-06	0.000127	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	5.54e-06	0.000126	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.5e-06	0.000125	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2—type 1 diabetes mellitus	5.45e-06	0.000124	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	5.44e-06	0.000124	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCG—type 1 diabetes mellitus	5.29e-06	0.000121	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.25e-06	0.00012	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2—type 1 diabetes mellitus	5.24e-06	0.00012	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.01e-06	0.000114	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	4.75e-06	0.000108	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAT—type 1 diabetes mellitus	4.48e-06	0.000102	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.41e-06	0.000101	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	4.33e-06	9.89e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	4.02e-06	9.18e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.01e-06	9.14e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	3.67e-06	8.37e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—type 1 diabetes mellitus	3.08e-06	7.03e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—INS—type 1 diabetes mellitus	2.97e-06	6.79e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	2.67e-06	6.09e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—type 1 diabetes mellitus	2.61e-06	5.95e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	2.45e-06	5.59e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	2.43e-06	5.56e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	2.34e-06	5.34e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	2.23e-06	5.09e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	2.13e-06	4.87e-05	CbGpPWpGaD
